Status:
COMPLETED
The Effect of Blood Flow Restriction With and Without Arginine on Physical Performance and Growth Hormone
Lead Sponsor:
University of Mary Hardin-Baylor
Conditions:
Blood Flow Restriction
Growth Hormone
Eligibility:
FEMALE
18-25 years
Phase:
NA
Brief Summary
The current study will investigate the effects of Blood Flow Restriction (BFR) training and L-arginine supplementation on recreationally trained female participants. In particular, it will compare per...
Detailed Description
The current study will investigate the effects of Blood Flow Restriction (BFR) training and L-arginine supplementation on recreationally trained female participants. In particular, it will compare per...
Eligibility Criteria
Inclusion
- Signed informed consent
- PAR-Q form complete and without contraindications
- Body Mass Index (BMI) of 18.5-29.9 kg/m2
- Stable body weight prior to participation in the study (fluctuation not exceeding 10 lbs. within the past 6 months
- Agreement not to change current diet or exercise program (other than adding the program for the purpose of this study)
Exclusion
- Any diagnosed orthopedic condition that prevents exercise
- BMI \> 29.9 kg/m2 or \< 18.5 kg/m2
- Affirmative answer to any of the questions presented on the PAR-Q form
- Are currently pregnant or planning to become pregnant during the study
- Currently taking blood pressure medication
Key Trial Info
Start Date :
September 4 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 25 2019
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04079010
Start Date
September 4 2019
End Date
November 25 2019
Last Update
April 2 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Mary Hardin-Baylor
Belton, Texas, United States, 76513